Breaking News

Elizabeth Arden Sees Setbacks in Holiday, Mass and Mid-Tier Retail

February 5, 2014

Q2 sales slip 10.6% to $418 million with declines in North America.

Elizabeth Arden, Inc. posted financial results for its second fiscal quarter ended Dec. 31, 2013. Net sales fell 10.6% to $418 million, with declines in North America.
 
Net sales of the company’s North America segment decreased by 13% for the second fiscal quarter as compared to the prior year period. According to the company, net sales were impacted by weaker than anticipated holiday retail sales and replenishment orders at a number of North American mass and mid-tier retail accounts, in part due to decreased consumer traffic at those retailers, and a higher volume of fragrance launch activity in the prior year. Performance at prestige retailers was solid and in-line with expectations. However, retail sales of Elizabeth Arden branded products in North American prestige retailers were strong, increasing by approximately 4%, which was better than the performance of the overall category.
 
Net sales of the company’s international segment decreased by 5%. The company’s Greater China region posted strong sales growth during the quarter, but weak performance in the European markets, where sales of fragrances were impacted by an increased level of highly promotional and discounted activity, drove the net sales decline for the quarter.
 
Net sales for the six months ended Dec. 31, 2013 fell 6.2% to $762 million. However, for the first six months, net sales of Elizabeth Arden branded skin care and color products rose by 6% in the aggregate and sales of fragrances were flat. Retail sales at the Company's Elizabeth Arden flagship counters have increased 16% in North America year over year since conversion, and retail sales at the company’s international flagship doors have increased 13% since conversion, or 21% excluding underperforming travel retail doors in Korea.
 
E. Scott Beattie, chairman, president and chief executive officer, commented, “Our results in the second quarter are highly sensitive to the performance of North American mass retailers, which was weak during the holiday season. We are confident that this is not an issue with the commercial execution of that business, the fragrance category or our brands, and that our recent results are not reflective of the underlying strength of our fragrance brand portfolio.”
 
Beattie continued, “Right now, the priorities for the Company are to return to more consistent profitability and improved return on invested capital. With the new senior leadership team, we are fully engaged in preparing and implementing plans targeted towards reaccelerating gross margin improvement and earnings growth. This is a comprehensive process that will be focused on improving the commercial execution of our international business, strengthening our travel retail and distribution relationships, better leveraging our overhead structure and re-deploying capital to priority markets and brands.”
 
  • Patent Activity: Colgate-Palmolive

    Patent Activity: Colgate-Palmolive

    December 6, 2016
    New oral care compositions, the use of radish root ferment filtrate in a cleanser and more.

  • Sparkle & Shine

    Sparkle & Shine

    Melissa Meisel, Associate Editor||November 21, 2016
    Glam packaging and upscale scent combos are big at Yankee Candle for Holiday 2016.

  • Cos Bar: Turning 40 and Hitting Fast Forward

    Cos Bar: Turning 40 and Hitting Fast Forward

    Christine Esposito, Associate Editor||November 21, 2016
    With a recent investor infusion, a new CEO and rebranding effort underway, this luxury beauty retailer has big plans.

  • The World Comes to Orlando

    The World Comes to Orlando

    Tom Branna , Editorial Director||December 1, 2016
    More than 1,600 chemists traveled to Florida for the IFSCC Congress

  • The Plex  Phenomenon

    The Plex Phenomenon

    Denise Costrini, Croda North America||December 1, 2016
    Croda details the hair-protecting qualities of bond multipliers and the company’s new bond-building formulation system.